US Broker Ratings

CorMedix Inc. (CRMD) Stock Analysis: Exploring a Promising 74.51% Potential Upside

CorMedix Inc. (NASDAQ: CRMD), a dynamic player in the biotechnology sector, has garnered significant attention among investors due to its impressive growth metrics and substantial upside potential. With a market..

Praxis Precision Medicines, Inc. (PRAX) Stock Analysis: Unpacking the 121% Potential Upside in the Biotechnology Sector

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical innovator, is making waves in the healthcare sector with its focus on central nervous system (CNS) disorders. Despite the company’s current..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: Healthcare Innovator with a 58% Upside Potential

Niagen Bioscience, Inc. (NAGE) stands out in the biotechnology sector as a dynamic player with a clear focus on healthy aging products. Based in Los Angeles, California, the company is..

Nutex Health Inc. (NUTX) Stock Analysis: A Deep Dive into Its 159.97% Potential Upside

For investors exploring opportunities in the healthcare sector, Nutex Health Inc. (NUTX) presents an intriguing proposition. With a remarkable potential upside of 159.97%, according to analyst projections, Nutex Health is..

Geron Corporation (GERN) Stock Analysis: Unveiling a Potential 174% Upside in the Biotech Space

Investors with a keen eye on the biotechnology sector may want to revisit Geron Corporation (NASDAQ: GERN), a company that could be poised for a significant upswing. With a market..

InMode Ltd. (INMD) Stock Analysis: Attractive Valuation with 7% Potential Upside

InMode Ltd. (NASDAQ: INMD) is a notable player in the healthcare sector, specifically within the medical devices industry. Known for its innovative approach, the Israeli-based company is a leading provider..

uniQure N.V. (QURE) Stock Analysis: Exploring a 138% Potential Upside in the Biotech Sector

For investors with an eye on the biotechnology sector, uniQure N.V. (NASDAQ: QURE) offers a compelling opportunity. This Amsterdam-based company, specializing in treatments for rare and devastating diseases, is making..

Xeris Biopharma Holdings, Inc. (XERS): Growth Potential in Biotech with a Robust Revenue Growth Outlook

Investors eyeing the biotechnology sector might find Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) an intriguing prospect, especially given its recent financial performance and promising pipeline of commercial products. Based in..

Intellia Therapeutics, Inc. (NTLA) Stock Analysis: Unveiling a Staggering Potential Upside of 106%

For investors with a keen eye on the biotechnology sector, Intellia Therapeutics, Inc. (NASDAQ: NTLA) presents a compelling case for consideration. Based in Cambridge, Massachusetts, this clinical-stage gene editing company..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Evaluating Growth Amidst Potential Volatility

Phibro Animal Health Corporation (NASDAQ: PAHC) stands at the intersection of innovation and necessity within the healthcare sector, offering a diverse portfolio of products that cater to animal health across..

Similarweb Ltd. (SMWB) Stock Analysis: Unpacking a 37% Upside Potential

Similarweb Ltd. (SMWB), a prominent player in the technology sector and software application industry, is gaining investor attention with its promising growth metrics and robust market positioning. Headquartered in Givatayim,..

Guidewire Software (GWRE) Stock Analysis: Unveiling a Potential 8.68% Upside

Guidewire Software, Inc. (NYSE: GWRE), a prominent player in the technology sector, specifically within the Software – Application industry, has captured considerable attention from investors due to its robust growth..

Diebold Nixdorf (DBD) Investor Outlook: Exploring a 28% Potential Upside in the Software Sector

Diebold Nixdorf Incorporated (NYSE: DBD) stands at an interesting crossroads within the technology sector, specifically in the software application industry. Headquartered in North Canton, Ohio, this long-standing company, originally founded..

Alkami Technology, Inc. (ALKT) Stock Analysis: A 48.55% Upside Potential for Investors

Alkami Technology, Inc. (NASDAQ: ALKT) is capturing the attention of the investment community with its robust growth metrics and promising analyst ratings. With a market cap of $2.69 billion, Alkami..

Tyler Technologies (TYL) Stock Analysis: Navigating Growth with a 26.55% Potential Upside

Tyler Technologies, Inc. (NYSE: TYL), a giant in the public sector software industry, is showing promise with a potential upside of 26.55%, according to analyst consensus. As an investor, understanding..

Intuit Inc. (INTU) Investor Outlook: Unpacking Potential 23.70% Upside Amidst Robust Revenue Growth

Intuit Inc. (NASDAQ: INTU) has long been a stalwart in the technology sector, particularly in the software application industry. With a market cap of $184.76 billion, the company stands as..

Cadence Design Systems, Inc. (CDNS): Investor Outlook with a 6.42% Upside Potential

Cadence Design Systems, Inc. (NASDAQ: CDNS), a prominent player in the technology sector, continues to demonstrate resilience and growth potential despite the recent challenges in the software application industry. With..

Paycom Software, Inc. (PAYC) Stock Analysis: Exploring a 15% Potential Upside for Investors

Paycom Software, Inc. (NYSE: PAYC) is carving its niche in the technology sector as a prominent player in the software application industry. Based in Oklahoma City, this company specializes in..

Uber Technologies, Inc. (UBER) Stock Analysis: Navigating Growth with a 14.72% Potential Upside

Uber Technologies, Inc. (NYSE: UBER), a titan in the technology sector, continues to capture investor attention with its robust growth metrics and promising outlook. With a market capitalization of $193.84..

AudioEye, Inc. (AEYE) Stock Analysis: Exploring a 69% Potential Upside

AudioEye, Inc. (NASDAQ: AEYE) is capturing investor attention with its significant growth potential in the highly competitive technology sector. As a key player in the Software – Application industry, AudioEye..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds